跳至主要内容
临床试验/NCT05498142
NCT05498142Unknown不适用

Predicting the Risk of Venous Thromboembolism in Critically Ill Patients: Validation of Pre-existing Risk Prediction Models and Development of a Prediction Model

University Medical Center Groningen0 个研究点目标入组 7,600 人开始时间: 2015年3月最近更新:
适应症

试验速览

阶段
不适用
入组人数
7,600
主要终点
Number of patients with in-hospital VTE

研究概览

简要总结

Introduction: Venous thrombosis (VTE), including both deep vein thrombosis (DVT) and pulmonary embolism (PE) remains a frequent complication in patients admitted to the Intensive Care Unit (ICU). Multiple prediction models for estimating the risk of VTE have been developed. However, many models have not been externally validated. The aim of this study is to perform a comprehensive external validation of pre-existing prediction models for predicting the risk of in-hospital VTE in critically ill patients. In case current risk assessment models fail, the investigators aim to additionally develop and internally validate a new risk prediction model.

Methods: During the first phase of the study the investigators will perform external validation of existing prediction models. The performance, discrimination, calibration and clinical usefulness of the models will be evaluated. In the second phase of the study, in case performance of current risk assessment models is deemed insufficient for clinical application, the investigators will develop a model for predicting the risk of in-hospital VTE in critically ill patients. A multivariable prediction model will be constructed using a combination of predefined candidate predictors. This model will be internally validated and performance will be compared with performance of existing VTE risk prediction models.

Dissemination: This protocol will be published online. This study will be reported according to the Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD) statement and this study will be submitted to a peer-reviewed journal for publication.

详细描述

Objective

  1. To perform external validation of existing prediction models (phase 1)
  2. To develop and internally validate a model for predicting the risk of in-hospital VTE in critically ill patients (phase 2)

Study design:

The objectives will require a large number of outcome events (see sample size calculation). To fulfill this requirement and to increase generalizability of the results, the intention is to collect data from several sources, which will include several types of study designs. The investigators currently have access to data from the Simple Intensive Care studies' (SICS-I and SICS-II; clinicalTrials.gov identifier:NCT02912624 and NCT03577405). In addition, an unpublished database that contains registry data from a community-hospital in the Netherlands will be used. Third, data from the prospective AFIB-ICU cohort study will be used. To further increase the sample size, the investigators are exploring additional collaboration with colleagues aiming to include more data.

In the final manuscript a table with the following descriptives of each data source will be included: study design, selection criteria, time period of conduct; data collection (prospective, retrospective); and types and definitions of included predictor and outcome variables.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Emergency admission

排除标准

  • Age < 18 years
  • Planned admission either after surgery or for other reasons

结局指标

主要结局

Number of patients with in-hospital VTE

时间窗: Initial hospital admission

VTE will be defined as any objectively proven event occurring during initial hospital admission. No screening protocol will be used. DVT will include acute thrombosis of lower-extremity veins (iliac, femoral or popliteal), confirmed by compression ultrasonography, venography, CT, MRI, or autopsy. Pulmonary embolism will be defined as acute thrombosis within the pulmonary vasculature as shown by ventilation-perfusion scan, CT angiography, or autopsy. We will include upper extremity DVT in the model but exclude venous thrombosis in any other site (e.g., portal vein thrombosis) as these may represent a different entity.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Frederik Keus

Principal Investigator

University Medical Center Groningen

相似试验